Skip to content

Using the MR-Base platform to investigate risk factors and drug targets for thousands of phenotypes

Research output: Contribution to journalArticle

Original languageEnglish
Article number113
Number of pages14
JournalWellcome Open Research
DateAccepted/In press - 22 Jul 2019
DatePublished (current) - 29 Jul 2019


Mendelian randomization (MR) uses genetic information to strengthen causal inference concerning the effect of exposures on outcomes. This method has a broad range of applications, including investigating risk factors and appraising potential targets for intervention. MR-Base has become established as a freely accessible, online platform, which combines a database of complete genome-wide association study results with an interface for performing Mendelian randomization and sensitivity analyses. This allows the user to explore millions of potentially causal associations. MR-Base is available as a web application or as an R package. The technical aspects of the tool have previously been documented in the literature. The present article is complimentary to this as it focuses on the applied aspects. Specifically, we describe how MR-Base can be used in several ways, including to perform novel causal analyses, replicate results and enable transparency, amongst others. We also present three use cases, which demonstrate important applications of Mendelian randomization and highlight the benefits of using MR-Base for these types of analyses.

    Research areas

  • genetics, sensitivity analysis, causality, causal inference, GWAS, Mendelian Randomization

Download statistics

No data available



  • Full-text PDF (final published version)

    Rights statement: This is the final published version of the article (version of record). It first appeared online via the Wellcome Trust at Please refer to any applicable terms of use of the publisher.

    Final published version, 756 KB, PDF document

    Licence: CC BY


View research connections

Related faculties, schools or groups